STAT3 and neoplasm: It has been clearly demonstrated that the JAK-STAT3 signalling pathway can affect tumour development by affecting the proliferation, survival, invasion, and immunosuppression of tumour cells, while also directly affecting tumour growth by affecting stromal cells to alter the inflammatory response or tumour microenvironment.